EMBL-EBI and Wellcome Trust Sanger Institute share the Wellcome Genome Campus. This proximity fosters close collaborations and contributes to an international and vibrant campus environment. Researchers are supported by easy access to scientific expertise, well-equipped facilities and an active seminar programme.

The EMBL-EBI–Sanger Postdoctoral (ESPOD) Programme builds on the strong collaborative relationship between the two institutes, offering projects which combine experimental (wet lab) and computational approaches.

Your role
Projects may be selected from pre-defined areas or proposed by the applicant. In the case of self-defined projects, the area of work must have been agreed with both EMBL-EBI and Sanger-based group leaders. The postdoctoral fellowships will be awarded in 2025, to start as soon as possible. Fellowships typically begin before the end of the year, but the start date may be delayed with the agreement of the group leaders. All ESPOD fellowships must be undertaken within 12 months of the fellowship being awarded.

Further information on the ESPOD 2024 projects please visit page below

Projects:

- Julio Saez Rodriguez (EMBL-EBI) & Carl Anderson (Sanger) - Multicellular molecular characterisation of inflammatory bowel disease
- Isidro Cortes Ciriano (EMBL-EBI) & Dr Leopold Parts (Sanger) - A reference of human structural variation impact
- Evangelia Petsalaki (EMBL-EBI) & Dr Omer Bayraktar (Sanger) - Predictive modelling of cell signaling across whole tumours to identify microenvironmental regulation and identify therapeutic targets in brain cancer
- Julio Saez Rodriguez (EMBL-EBI) & Prof Muzlifah Haniffa, Dr Mo Lotfollahi (Sanger) - Generative modelling of single-cell data by linking textual and molecular information to characterise cells in healthy and diseased skin
- Isidro Cortes Ciriano (EMBL-EBI) & Roser Vento-Tormo (Single-cell multiomics to characterise how high grade serous ovarian cancer (HGSOC) originates and evolves)
- John Lees (EMBL-EBI) & Dr Josie Bryant (Sanger) - New bioinformatic and statistical approaches to longitudinal metagenomics
- Ewan Birney, Tomas Fitzgerald (EMBL-EBI) & Hilary Martin, Klaudia Walter (Sanger) - Integrating SNV and CNV signals for trait association testing in large human cohorts

Benefits and Contract Information
- Financial incentives: depending on circumstances, monthly family/marriage allowance of £272, monthly child allowance of £328 per child. Generous stipend reviewed yearly, pension scheme, death benefit, long-term care, accident-at-work and unemployment insurances
- Hybrid working arrangements
- Private medical insurance for you and your immediate family (including all prescriptions and generous dental & optical cover)
- Generous time off: 30 days annual leave per year, in addition to eight bank holidays
- Relocation package
- Campus life: Free shuttle bus to and from work, on-site library, subsidised on-site gym and cafeteria, casual dress code, extensive sports and social club activities (on campus and remotely)
- Family benefits: On-site nursery, child sick leave, generous parental leave, holiday clubs on campus and monthly family and child allowances
- Contract duration: This position is a 3 year contract
- Salary: Stipend Year 1 (Monthly Rate of £3,165 after tax, total package will be dependant on family circumstances)
- International applicants: We recruit internationally and successful candidates are offered visa exemptions. Read more on our page - for international applicants.
- Diversity and inclusion: At EMBL-EBI, we strongly believe that inclusive and diverse teams benefit from higher levels of innovation and creative thought. We encourage applications from women, LGBTQ+ and individuals from all nationalities.
- Job location: This role is based in Hinxton, near Cambridge, UK. You will be required to relocate if you are based overseas and you will receive a generous relocation package to support you.